Skip to content

Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients with Head and Neck Cancer

Preventive Randomized Study Regarding Jaw- and Swallowing Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer: the Effect of Preventive Intervention for Trismus, Swallowing Function and Quality of Life

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04005521
Acronym
HNC
Enrollment
80
Registered
2019-07-02
Start date
2019-06-13
Completion date
2028-07-31
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deglutition Disorders, Head and Neck Neoplasm, Trismus

Brief summary

The study includes patients with tumors of the oropharynx, larynx and hypopharynx scheduled to receive radiotherapy with curative intent (+/- chemotherapy). The patients will be randomized into either an intervention group (performing a preventive jaw- and swallowing exercise protocol before and during radiotherapy) or a control group no performing a exercise protocol. All patients will be encouraged to eat or drink for as long as possible during the therapy. All patients will meet with a speech-language therapist weekly during radiotherapy.

Interventions

Preventive, structured exercise protocol

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Head and neck cancer (tumors of the oropharynx, pharynx, hypopharynx and larynx) * Receiving radiohterpay (+/- chemotherapy) with curative intent * No previous trismus or dysphagia

Exclusion criteria

* Surgery due to head and neck cancer * Previous treatment for head and neck cancer * Tracheostomized patients * No teeth * Inability to perform exercise intervention * Inability to independently fill out questionnaires in Swedish * Previous neurologic or neuromuscular disease

Design outcomes

Primary

MeasureTime frameDescription
Maximal Interincisal opening (MIO)1 month post radiotherapyJaw opening measured in millimeters. A MIO \<36 mm is considered as trismus. i.e. limited jaw-opening.
Swallowing ability1 month after radiotherapySwallowing ability measured with Functional Endoscopic Examination of Swallowing (FEES)

Secondary

MeasureTime frameDescription
Dysphagia related symtomsUp to 5 years post radiotherapyPRO measured with M.D Anderson Dysphagia Inventory (MDADI). This is a cancer-specific instrument measuring dysphagia, social function and quality of life in head and neck cancer patients. It consists of 19 items in four domains; emotional, physical, functional and global quality of life. The range for each subscale is 20-100 where 100 indicates best possible swallowing, i.e. better outcome.
Trismus and jaw related symptomsUp to 5 years post radiotherapyPatient Reported Outcomes (PRO) measured with Gothenburg Trismus Questionnaire (GTQ). The GTQ consists of 21 items divided into 3 domains; Jaw related problems, Eating limitations and Muscular tension and eight single items concerning facial pain, limitations in mouth opening and inabilities to function on social and working contexts. The GTQ domains range from 0-100 where 0 equals to absence of symtoms and 100 equals worst possible symptoms.
Health related quality of life (HRQL)Up to 5 years post radiotherapyMeasured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) core questionnaire (c30). Consists of 30 items divided into six functional domains (Physical, Role, Cognitive, Emotional, and Social Functioning and Global Quality of life), three symptom scales (Fatigue, Pain, and Nausea/Vomiting) and six single items (Constipation, Diarrhea, Insomnia, Dyspnea, Appetite Loss, and Financial Difficulties). All domains range from 0-100. For the functional domains a higher score indicates good function, while for all other domains a high score indicates a high prevalence of symtoms, i.e. worse HRQL.
Swallowing abilityUp to 5 years post radiotherapySwallowing ability measured with FEES
Maximal Interincisal opening (MIO)Up to 5 years post radiotherapyJaw opening measured in millimeters

Other

MeasureTime frameDescription
Incremental Cost Effectiveness Ratio (ICER)Up to 5 years post radiotherapyIncremental cost for each QALY for the intervention group will be calculated using a Markov model which combines the costs and EQ-5D. The ICER will then be compared to the maximum willingness to pay level which is SEK 500,000 (€55,000) according to the Swedish National Board of Health and Welfare.
Quality Adjusted Life Years (QALY)Up to 5 years post radiotherapyQALY is a measurement that combines health-related quality of life (HRQL) and life expectancy in one index. The index range between 0 and 1, where 0 equals death and 1 represents perfect health. Thus, 1 QALY corresponds to 1 year of perfect health. This is calculated using the EQ-5D.
CostUp to 5 years post radiotherapyThe cost of intervention compared to usual care. Costs in Swedish crowns (SEK) for the intervention and all visits to healthcare during 5 years will be recorded.
Quality of life for cost-effectiveness analysisUp to 5 years post radiotherapyThe outcomes of intervention compared to usual care using European Quality of life 5 dimensions (EQ5D).

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026